Virus News and Research

Latest Virus News and Research

Modular nanoparticles developed for targeted drug delivery and neutralizing biological agents

Engineers at the University of California San Diego have developed modular nanoparticles that can be easily customized to target different biological entities such as tumors, viruses or toxins.

30 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

Study uncovers interplay of lifestyle choices and DNA methylation in gastric neoplasia risk

A new paper in The Lancet eBioMedicine explores whether these changes predict the future risk of stomach tumors and how epigenetic changes interact with environmental and lifestyle factors in this process.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

Current jargon on antibiotic resistance fails to stick or scare, study finds

Researchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like "AMR" and "antimicrobial resistance" are poorly remembered and do not evoke sufficient risk perception, highlighting the need for improved public health messaging.

29 Oct 2023

Machine learning sheds light on mental health challenges faced by HCWs during COVID-19 pandemic

Machine learning reveals unique mental health struggles among healthcare workers during the COVID-19 pandemic, highlighting the urgent need for specialized support. The study analyzed therapy transcripts to show how healthcare professionals faced distinct challenges, including heightened anxiety and depression.

29 Oct 2023

AI-nanopore platform can detect SARS-CoV-2 variants with high accuracy

A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus' hold over our society.

27 Oct 2023

A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.

27 Oct 2023

Study helps identify children at the highest risk of severe RSV infection

A new study helps to identify children who are at the highest risk of a severe respiratory syncytial virus (RSV) infection and who would thus benefit most from new RSV prevention measures.

26 Oct 2023

New AI-nanopore platform could revolutionize COVID-19 testing

A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus' hold over our society.

26 Oct 2023

NF-κB activation during COVID-19 and its impact on patients with hypertension

Researchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation.

25 Oct 2023

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Zika virus infection in pregnant rhesus macaques slows fetal growth and affects how infants and mothers interact in the first month of life, according to a new study from researchers at the California National Primate Research Center at the University of California, Davis.

25 Oct 2023

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

Community immunity: Steering the evolutionary course of SARS-CoV-2

Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.

24 Oct 2023

AI tool effectively detects distress in hospital workers' conversations

An artificial intelligence tool effectively detected distress in hospital workers' conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.

24 Oct 2023

Previous
1
...
59
60
61
62
63
64
65
...
1541
Next

Virus News and Research

Latest Virus News and Research

Modular nanoparticles developed for targeted drug delivery and neutralizing biological agents

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

Study uncovers interplay of lifestyle choices and DNA methylation in gastric neoplasia risk

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Current jargon on antibiotic resistance fails to stick or scare, study finds

Machine learning sheds light on mental health challenges faced by HCWs during COVID-19 pandemic

AI-nanopore platform can detect SARS-CoV-2 variants with high accuracy

A new era of vaccines leaves old questions about prices unanswered

Study helps identify children at the highest risk of severe RSV infection

New AI-nanopore platform could revolutionize COVID-19 testing

NF-κB activation during COVID-19 and its impact on patients with hypertension

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

Epidemic: What good is a vaccine when there is no rice?

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Community immunity: Steering the evolutionary course of SARS-CoV-2

AI tool effectively detects distress in hospital workers' conversations

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in